Des services pour PMB
Accueil
Détail de l'auteur
Auteur Ruby Srivastava |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la rechercheArtificial Intelligence Multiomics in Precision Oncology / Ruby Srivastava (2023) / 978-1-4438-9520-0
Titre : Artificial Intelligence Multiomics in Precision Oncology Type de document : texte imprimé Auteurs : Ruby Srivastava Editeur : cambridge scolars publishing Année de publication : 2023 Importance : 505p. Présentation : hardcover Format : 21cm ISBN/ISSN/EAN : 978-1-4438-9520-0 Langues : Anglais (eng) Langues originales : Anglais (eng) Catégories : 004 Informatique. Science et technologie de l'informatique.:004.8 Intelligence artificielle Index. décimale : 004 Informatique Résumé : Advances in next-generation technology (NGS) coupled with a deep understanding of cancer biology have promoted the rational design of target therapy towards precision oncology. Artificial Intelligence (AI)-integrated machine learning techniques are also increasingly used today to tackle the challenges of scalability and high dimensionality data and to transform multiomics data into clinically actionable knowledge. AI tools are used to support clinical decision making and improve clinical efficiency, while delivering safe and high value care. This book provides comprehensive analysis of such techniques and advancements of AI-based clinical cancer research in the improvement of cancer prognosis and diagnosis, resulting in enhanced prediction rates and survival of cancer patients. Artificial Intelligence Multiomics in Precision Oncology [texte imprimé] / Ruby Srivastava . - cambridge scolars publishing, 2023 . - 505p. : hardcover ; 21cm.
ISBN : 978-1-4438-9520-0
Langues : Anglais (eng) Langues originales : Anglais (eng)
Catégories : 004 Informatique. Science et technologie de l'informatique.:004.8 Intelligence artificielle Index. décimale : 004 Informatique Résumé : Advances in next-generation technology (NGS) coupled with a deep understanding of cancer biology have promoted the rational design of target therapy towards precision oncology. Artificial Intelligence (AI)-integrated machine learning techniques are also increasingly used today to tackle the challenges of scalability and high dimensionality data and to transform multiomics data into clinically actionable knowledge. AI tools are used to support clinical decision making and improve clinical efficiency, while delivering safe and high value care. This book provides comprehensive analysis of such techniques and advancements of AI-based clinical cancer research in the improvement of cancer prognosis and diagnosis, resulting in enhanced prediction rates and survival of cancer patients. Exemplaires(0)
Disponibilité aucun exemplaire



